leisure time -WSS

leisure time

author：knowledge 2025-09-30 00:37:48 - browse：3457

BIO is proceeding with a restructuring after its new CEO took over. Lane Turner/The Boston Globe

WASHINGTON — The Biotechnology Innovation Organization on Monday is announcing a significant restructuring accompanied by a shakeup, according to five sources familiar with the planning.

A few senior leaders are expected to depart as part of the reorganization. Chief Science Officer Cartier Esham, Chief Public Affairs and Marketing Officer Rich Masters, and Chief Policy Officer John Murphy are expected to leave, four sources said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Why Novartis is going to walk from its acquisition of MorphoSys

WSS

Man who had jail sentence commuted by Trump arrested again

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Seattle police shoot person suspected in downtown stabbing

Ebola public health emergency is over, WHO declares

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

The high cost of giving birth even with insurance

Why the Crimean Bridge is key to Russia's war in Ukraine

Supreme Court strikes down use of affirmative action

Why Novartis is going to walk from its acquisition of MorphoSys

United colonoscopy coverage change 'may cost lives,' doctors say

Researchers separate signal from noise in heart wearable data

23andMe had bad news about my health. I wish a person had delivered it

Bernie brings in new pharma CEOs to talk drug prices

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Updated Covid vaccine has 54% effectiveness, new study suggests

focus

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Readout Newsletter: Amgen, Regeneron, BGI Group and more

340B reform proposal comes out of Senate working group

Norman Reedus' Daryl Dixon

Why Novartis is going to walk from its acquisition of MorphoSys

TikTok cracks down on users posting about weight loss drugs

leisure time

hotspot

explore

focus